The global Snake Trippetide market was valued at USD 152.7 million and is projected to reach  USD 289.5 million by 2032 at a CAGR of 7.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.Snake Trippetide, a bioactive peptide derived from snake venom, represents a fascinating intersection of biotechnology and...